Welcome to COMPPARE
A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer
Recent news
September is Prostate Cancer Awareness Month
If you are a man between the ages of 55 and 69, September is a good time to schedule a prostate screening, one that includes both a PSA blood test…
COMPPARE Enrolls 1,500th Proton Patient, Reaches…
The COMPPARE Coordinating Center announced today that the study has enrolled its 1,500th proton prostate cancer patient and has closed enrollment for…
COMPPARE Achieves 75% Enrollment Milestone
The COMPPARE Coordinating Center announced today that the study achieved 75% enrollment on May 3, 2022. COMPPARE realized both a remarkable…
For participants
About COMPPARE
Study goals, benefits, and other details
Locations
More than 45 partner sites across the US
Meet the Team
COMPPARE clinicians, researchers, patients, and other stakeholders
For Healthcare providers
Consortium Materials
Study-specific materials and other information.
ClinicalTrials.gov
Privately and publicly funded clinical studies conducted around the world.
VTOC Login
Medical Team sign-in page